Singapore Exchange

<h1>Singapore Exchange</h1> <p>Listing-reform anchors: the Mainboard profit test became effective in <strong>October 2025</strong> (<code>october_2025_effective</code>) and uses consolidated <strong>pre-tax profit in the latest financial year</strong> (<code>pretax_profit_latest_fy</code>); the 2025 reforms moved toward <strong>consolidation toward SGX RegCo</strong> (<code>consolidation_toward_regco</code>) for listing-suitability and prospectus review while MAS retained statutory oversight (<a href="https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review">MAS Equities Market Review</a>; <a href="https://www.mas.gov.sg/-/media/mas/news/media-releases/2025/annex-a---final-report.pdf">MAS final report</a>, accessed 16 August 2026).</p> <p>Singapore Exchange (SGX) is the integrated securities and derivatives exchange group through which companies list equity, trust, and bond instruments in Singapore, and through which investors trade shares, futures, foreign-exchange contracts, and commodity derivatives. Formed in 1999 by merging the Stock Exchange of Singapore and the Singapore International Monetary Exchange, SGX operates the trading platforms, the Central Depository clearing house, and Singapore Exchange Regulation (SGX RegCo), which acts as frontline regulator for listings and market conduct. The Monetary Authority of Singapore (MAS) remains the statutory capital-markets regulator under the Securities and Futures Act. SGX is therefore a market infrastructure institution at the centre of Singapore's <a href="/en/knowledge/article/sgkb.economy-finance.banking-and-financial-hub">financial hub</a> — distinct from banks, fund managers, and MAS itself, but essential to how capital is raised, priced, and transferred; dated SGX turnover, listing, REIT, and reform figures are maintained in <a href="/en/knowledge/dataset/sgkb.data.capital-markets-anchors">capital markets anchors</a>.</p> <h2>SGX Group structure and regulatory roles</h2> <p>SGX is not a single venue but a group of licensed entities under Singapore Exchange Limited, a company listed on its own Mainboard since 2000. The securities trading arm (SGX-ST) runs the cash equities market; the derivatives exchange (SGX-DT) lists futures and options; Central Depository (Pte) Limited (CDP) clears, settles, and holds securities; and SGX RegCo enforces listing rules and market conduct. MAS supervises the group under the Securities and Futures Act and related legislation, including the Exchanges (Demutualisation and Merger) Act 1999 that created the integrated exchange on 1 December 1999 (<a href="https://www.mas.gov.sg/regulation/acts/Exchanges-Demutualisation-and-Merger-Act">MAS, accessed Aug 2026</a>). This split matters for retrieval: SGX RegCo decides whether a company may list and whether disclosures meet rule requirements, while MAS sets capital-markets law, approves exchange licences, and retains statutory powers over prospectus registration and enforcement. Confusing the exchange operator with MAS leads to wrong answers about who licenses brokers or sets monetary policy (see <a href="/en/knowledge/article/sgkb.economy-finance.mas-and-monetary-policy">mas and monetary policy</a>).</p> <h2>Mainboard, Catalist, and market benchmarks</h2> <p>Singapore's listed equities trade on two boards with different admission philosophies. The Mainboard targets more established issuers and sets quantitative admission tests — including, since 29 October 2025, a profit test requiring consolidated pre-tax profit of at least S$10 million in the latest financial year, reduced from S$30 million under reforms recommended by MAS's Equities Market Review Group (<a href="https://www.mas.gov.sg/-/media/mas/news/media-releases/2025/annex-a---final-report.pdf">MAS final report, accessed Aug 2026</a>). Catalist, launched in 2007, is a sponsor-supervised board for growth companies: aspirant issuers engage an approved sponsor for due diligence and ongoing support, and Catalist does not impose the Mainboard's minimum profit threshold, though spread and governance requirements still apply. The benchmark Straits Times Index (STI) tracks large Mainboard constituents; in 2025 the STI closed at a record 4,655.38 on 30 December and delivered a 22.7% price return, or 28.8% with reinvested dividends, according to SGX market statistics (<a href="https://links.sgx.com/1.0.0/corporate-announcements/H3L2VGGP9YCWRZI2/">SGX, accessed Aug 2026</a>). STI-linked products remain a major share of cash-market turnover: STI constituent stocks accounted for about 80% of SGX securities trading value in 2025 (<a href="https://www.straitstimes.com/business/companies-markets/capital-markets-currencies/sgxs-securities-daily-average-value-2025-jumps-21-highest-2010">The Straits Times, accessed Aug 2026</a>).</p> <h2>Derivatives, FX, and commodities</h2> <p>SGX's derivatives franchise is often larger in contract volume than its cash equities market and serves regional hedging and investment demand beyond Singapore-listed shares. In 2025 derivatives volume across equities, foreign exchange, and commodities rose 10% to a record 329 million contracts; foreign-exchange futures volume reached 79.3 million contracts for the full year, also a record (<a href="https://links.sgx.com/1.0.0/corporate-announcements/H3L2VGGP9YCWRZI2/">SGX, accessed Aug 2026</a>). Flagship contracts include MSCI Singapore index futures (SiMSCI), China A50 and Nifty index products, USD/CNH FX futures, and iron ore derivatives — the iron ore suite recorded its seventh consecutive annual volume record in 2025 (<a href="https://www.straitstimes.com/business/companies-markets/capital-markets-currencies/sgxs-securities-daily-average-value-2025-jumps-21-highest-2010">The Straits Times, accessed Aug 2026</a>). This derivatives depth is a separate pillar of Singapore's capital-markets identity from domestic IPO activity: institutions use SGX to manage currency, commodity, and regional equity risk even when they do little business in Singapore-listed stocks.</p> <h2>Listing process and the disclosure-based shift</h2> <p>Until 2025, a Mainboard IPO typically required parallel review by SGX RegCo on listing suitability and by MAS on prospectus registration under Part 13 of the Securities and Futures Act — a dual-track process that issuers said lengthened time-to-market (<a href="https://www.mas.gov.sg/-/media/mas/news/media-releases/2025/annex-a---final-report.pdf">MAS final report, accessed Aug 2026</a>). MAS and SGX RegCo have since moved toward consolidating listing suitability and prospectus review under SGX RegCo for Mainboard listings, with MAS delegating prospectus lodgment and registration functions while retaining statutory oversight (<a href="https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review">MAS, accessed Aug 2026</a>). The broader policy direction is a more disclosure-based regime: lower prescriptive merit tests at admission, clearer ongoing disclosure obligations, and heavier reliance on market discipline, research coverage, and enforcement rather than ex-ante approval of business quality. Post-listing oversight has also been recalibrated — for example, SGX RegCo removed the Financial Watch List in October 2025 and shifted toward targeted queries and issuer announcements of sustained losses (<a href="https://www.mas.gov.sg/-/media/mas/news/media-releases/2025/annex-a---final-report.pdf">MAS final report, accessed Aug 2026</a>). Companies considering a Singapore listing still need sponsor or issue-manager support, audited financials, and continuous disclosure after listing; the reforms mainly reduce duplicated regulator engagement and align quantitative thresholds with other major exchanges.</p> <h2>Clearing, settlement, and how investors hold shares</h2> <p>Most Singapore retail investors hold SGX-listed securities through CDP direct accounts or broker accounts linked to CDP's book-entry system. CDP provides integrated clearing, settlement, and depository services — including dividend payments and corporate-action processing — so trades settle through the central counterparty rather than bilateral delivery between buyers and sellers (<a href="https://www.mas.gov.sg/-/media/mas/news/media-releases/2025/annex-a---final-report.pdf">MAS final report, accessed Aug 2026</a>). From 15 July 2026, rule changes allow depository agents to hold client securities in omnibus broker custody accounts, aligning with practice in several other markets and enabling brokers to offer portfolio services, fractional trading, and robo-advisory wrappers for local shares; retail investors may still keep direct CDP accounts if they prefer (<a href="https://links.sgx.com/FileOpen/20260701%20SGX%20custody%20structure%20enhancements%20to%20take%20effect%20from%20July%20board%20lot%20reduction%20in%20October.ashx?App=Announcement&amp;FileID=895053">SGX, accessed Aug 2026</a>). Trading mechanics are also changing: from 5 October 2026, the standard board lot for eligible instruments priced above S$10 and up to S$100 falls from 100 units to 10, and for instruments above S$100 from 100 units to 1, lowering minimum ticket sizes for high-priced bank and REIT counters (<a href="https://links.sgx.com/FileOpen/20260701%20SGX%20custody%20structure%20enhancements%20to%20take%20effect%20from%20July%20board%20lot%20reduction%20in%20October.ashx?App=Announcement&amp;FileID=895053">SGX, accessed Aug 2026</a>). Board lot size is a trading convention, not a separate securities law: brokerage and exchange fees still apply per transaction.</p> <h2>REITs, IPOs, and capital raising</h2> <p>Singapore is a major listing venue for real estate investment trusts (REITs) and property trusts. As of the fourth quarter of 2025, Singapore had 41 REITs and property trusts with combined market capitalisation of about S$104 billion, representing roughly 10% of overall listed equity market value (<a href="https://www.reitas.sg/wp-content/uploads/2026/03/SGX-Research-SREIT-Property-Trusts-Chartbook-Q4_2025.pdf">REITAS/SGX chartbook, accessed Aug 2026</a>). REIT issuance has driven recent IPO momentum: MAS reported that IPOs raised over S$2 billion in 2025, the strongest year since 2019, with REIT listings a major contributor alongside a handful of operating-company debuts (<a href="https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review">MAS, accessed Aug 2026</a>). The listing count nonetheless faces structural pressure — delistings have exceeded new listings in several recent years, and market participants continue to debate Catalist quality — so capital-raising headlines can improve even while the total number of listed securities drifts lower. Cross-border connectivity initiatives, including a proposed dual-listing bridge with Nasdaq for larger growth companies (market capitalisation from about S$2 billion) and a planned Global Listing Board with harmonised disclosure, aim to widen the issuer pipeline beyond purely domestic candidates (<a href="https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review">MAS, accessed Aug 2026</a>).</p> <h2>Market revitalisation and 2024–2026 reforms</h2> <p>From August 2024, MAS chaired an Equities Market Review Group to recommend demand- and supply-side measures after years of thin liquidity and weak small-cap participation relative to regional peers. Implemented and announced measures include a S$5 billion Equity Market Development Programme (EQDP) placing public-sector capital with selected fund managers to build Singapore-equity mandates — S$3.95 billion allocated across nine managers by November 2025 (<a href="https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review">MAS, accessed Aug 2026</a>); a S$30 million &quot;Value Unlock&quot; package for listed-company investor relations and strategy; GEMS research-grant enhancements; tax incentives for funds investing substantially in Singapore-listed equities; and trading-structure changes such as board-lot reduction and broker custody. Early indicators cited by MAS include average daily securities turnover of S$1.53 billion in the third quarter of 2025, up 16% year-on-year and the highest since the first quarter of 2021, and full-year 2025 securities daily average value of almost S$1.5 billion, up 21% and the highest since 2010 (<a href="https://www.mas.gov.sg/news/media-releases/2025/review-group-completes-equities-market-review">MAS, accessed Aug 2026</a>; <a href="https://links.sgx.com/1.0.0/corporate-announcements/H3L2VGGP9YCWRZI2/">SGX, accessed Aug 2026</a>). Revitalisation is therefore a coordinated public-policy programme around SGX infrastructure, not a single rule change inside the exchange — and its success depends on sustained institutional and retail demand, not only on listing-rule liberalisation.</p>

简介

新加坡交易所

上市改革要点:主板盈利测试于2025 年十月生效(october_2025_effective),采用最近一个财政年度的合并税前利润(pretax_profit_latest_fy);2025 年的改革推动上市适格性审查和招股说明书审查向SGX RegCo整合(consolidation_toward_regco),同时MAS保留法定监督权(MAS股票市场检讨;MAS最终报告,查阅于 2026 年八月 16 日)。

新加坡交易所(SGX)是综合性证券及衍生品交易所集团,公司可通过该集团在新加坡上市股票、信托和债券工具,投资者则可交易股票、期货、外汇合约和商品衍生品。SGX于 1999 年由新加坡证券交易所和新加坡国际金融交易所合并成立,运营交易平台、中央存管公司的结算机构,以及负责上市和市场行为一线监管的新加坡交易所监管公司(SGX RegCo)。新加坡金融管理局(MAS)依据《证券与期货法》继续担任资本市场法定监管机构。因此,SGX是处于新加坡金融中心核心的市场基础设施机构——它有别于银行、基金管理公司和MAS本身,但对资本筹集、定价和转移至关重要;有关SGX成交额、上市、房地产投资信托基金(REIT)及改革的带日期数据,收录于资本市场要点数据集。

SGX集团架构与监管职责

SGX并非单一交易场所,而是由新加坡交易所有限公司旗下多个持牌实体组成的集团。该公司自 2000 年起在自己的主板上市。证券交易部门(SGX-ST)运营现金股票市场;衍生品交易所(SGX-DT)上市期货和期权;中央存管私人有限公司(CDP)负责证券结算、交收和托管;SGX RegCo则执行上市规则并监管市场行为。MAS依据《证券与期货法》及相关法规监管该集团,其中包括创设综合交易所的《交易所(去互助化及合并)法案 1999》;综合交易所于 1999 年十二月 1 日成立(MAS,查阅于 2026 年八月)。这种职责划分对信息检索很重要:SGX RegCo决定公司能否上市,以及披露是否符合规则要求;MAS则制定资本市场法律、批准交易所牌照,并保留招股说明书注册和执法的法定权力。把交易所运营方与MAS混为一谈,会导致对谁负责发放经纪商牌照或制定货币政策的错误回答(参见MAS与货币政策)。

主板、凯利板与市场基准

在新加坡上市的股票在两个上市板块交易,两者的准入理念不同。主板面向较成熟的发行人,并设有量化准入测试——包括自 2025 年十月 29 日起实行的盈利测试,要求最近一个财政年度的合并税前利润至少达到 10 million 新元;在MAS股票市场检讨小组提出改革建议之前,门槛为 30 million 新元(MAS最终报告,查阅于 2026 年八月)。凯利板于 2007 年推出,是由保荐人监督的成长型公司板块:拟上市发行人须聘请获认可的保荐人进行尽职调查并提供持续支持。凯利板没有主板的最低盈利门槛,但仍适用股权分布和治理要求。海峡时报指数(STI)是追踪大型主板成分股的基准;根据SGX市场统计,STI于 2025 年十二月 30 日以 4,655.38 点创收市纪录,价格回报率为 22.7%,计入股息再投资后为 28.8%(SGX,查阅于 2026 年八月)。与STI挂钩的产品仍占现金市场成交额的重要部分:2025 年,STI成分股约占SGX证券交易额的 80%(《海峡时报》,查阅于 2026 年八月)。

衍生品、外汇与商品

SGX的衍生品业务按合约成交量计算,规模往往大于现金股票市场,并服务于新加坡上市股票以外的区域对冲和投资需求。2025 年,股票、外汇和商品衍生品总成交量上升 10%,达到创纪录的 329 百万份合约;全年外汇期货成交量达到 79.3 百万份合约,同样创下纪录(SGX,查阅于 2026 年八月)。旗舰合约包括MSCI新加坡指数期货(SiMSCI)、中国A50 和Nifty指数产品、美元/离岸人民币外汇期货,以及铁矿石衍生品——铁矿石系列产品在 2025 年连续第七年创年度成交量纪录(《海峡时报》,查阅于 2026 年八月)。衍生品市场的深度,是新加坡资本市场定位中有别于本地首次公开募股(IPO)活动的另一支柱:即使机构在新加坡上市股票上的业务不多,也会利用SGX管理货币、商品和区域股票风险。

上市流程与转向披露为本的制度

2025 年以前,主板IPO通常需要SGX RegCo平行审查上市适格性,并由MAS依据《证券与期货法》第 13 部分审查招股说明书是否注册;发行人表示,这种双轨流程拉长了上市所需时间(MAS最终报告,查阅于 2026 年八月)。此后,MAS和SGX RegCo已推动将主板上市适格性和招股说明书审查整合至SGX RegCo,由MAS转授招股说明书提交和注册职能,同时保留法定监督权(MAS,查阅于 2026 年八月)。更广泛的政策方向是转向更以披露为本的制度:降低上市准入时的规定性实质审查测试,明确持续披露义务,并更多依靠市场纪律、研究覆盖和执法,而非事前批准企业质量。上市后的监督也经过调整——例如,SGX RegCo于 2025 年十月取消财务观察名单,转而采用有针对性的问询,并要求发行人公告持续亏损情况(MAS最终报告,查阅于 2026 年八月)。计划在新加坡上市的公司仍需获得保荐人或发行经理支持、提供经审计财务报表,并在上市后持续披露;改革主要减少与监管机构的重复接洽,并使量化门槛与其他主要交易所接轨。

结算、交收与投资者持股方式

大多数新加坡散户投资者通过CDP直接账户,或关联至CDP簿记系统的经纪账户持有SGX上市证券。CDP提供综合结算、交收和存管服务,包括股息支付及公司行动处理,因此交易通过中央对手方结算,而非买卖双方双边交割(MAS最终报告,查阅于 2026 年八月)。自 2026 年七月 15 日起,规则变更允许存管代理通过综合经纪托管账户持有客户证券,使本地做法与其他几个市场接轨,并让经纪商能够为本地股票提供投资组合服务、碎股交易和机器人投顾包装服务;散户投资者仍可按个人意愿继续使用CDP直接账户(SGX,查阅于 2026 年八月)。交易机制也在变化:自 2026 年十月 5 日起,价格高于 10 新元且不超过 100 新元的合资格工具,其标准交易单位将从 100 单位降至 10 单位;价格高于 100 新元的工具,其标准交易单位将从 100 单位降至 1 单位,从而降低高价银行股和房地产投资信托基金股票的最低交易金额(SGX,查阅于 2026 年八月)。标准交易单位是交易惯例,并非独立的证券法律;每笔交易仍须支付经纪和交易所费用。

房地产投资信托基金、IPO与资本筹集

新加坡是房地产投资信托基金(REIT)和房地产信托的重要上市地点。截至 2025 年第四季度,新加坡有 41 只REIT和房地产信托,合计市值约 104 billion 新元,约占整体上市股票市场价值的 10%(REITAS/SGX图表集,查阅于 2026 年八月)。REIT发行带动近期IPO势头:MAS报告称,2025 年IPO筹资超过 2 billion 新元,是 2019 年以来表现最好的一年;REIT上市是重要推动因素,另有少数运营公司首次上市(MAS,查阅于 2026 年八月)。不过,上市数量仍面临结构性压力——近年有好几年的退市数量超过新上市数量,市场参与者也持续讨论凯利板的质量;因此,即使筹资消息有所改善,上市证券总数仍可能逐渐减少。跨境互联举措包括拟与Nasdaq为较大型成长型公司建立双重上市桥梁(市值约从 2 billion 新元起),以及计划设立披露要求协调一致的全球上市板,目标是扩大潜在发行人来源,使其超越纯粹的本地候选企业(MAS,查阅于 2026 年八月)。

市场活化与 2024–2026 年改革

自 2024 年八月起,MAS主持股票市场检讨小组,在多年流动性不足、小型股参与度弱于区域同业后,负责提出需求侧和供给侧措施。已实施及已公布的措施包括:规模为 5 billion 新元的股票市场发展计划(EQDP),将公共部门资金交由特选基金管理公司管理,以建立新加坡股票投资委托;截至 2025 年十一月,九家管理公司共获分配 3.95 billion 新元(MAS,查阅于 2026 年八月);为上市公司投资者关系和战略提供 30 million 新元的“价值释放”配套;加强GEMS研究补助;为大部分投资于新加坡上市股票的基金提供税务优惠;以及缩小标准交易单位、经纪商托管等交易结构调整。MAS引用的早期指标包括:2025 年第三季度证券日均成交额为 1.53 billion 新元,同比增长 16%,为 2021 年第一季度以来最高;2025 年全年证券日均成交额接近 1.5 billion 新元,上升 21%,为 2010 年以来最高(MAS,查阅于 2026 年八月;SGX,查阅于 2026 年八月)。因此,市场活化是围绕SGX基础设施协调推进的公共政策计划,并非交易所内部的一项单独规则变更;其成效取决于机构和散户需求能否持续,而不只取决于上市规则放宽。